ProKidney(PROK) - 2022 Q1 - Quarterly Report

Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the transition period from to Commission file number: 001-40560 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III (Exact Name of Registrant as Specified in Its Charter) Cayman I ...